canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
.jpg.jpg)
- Bild-Infos
- Download
- 2 weitere Medieninhalte
Ein Dokument
CanSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
EU-funded canSERV Project Consortium Invites Researchers to Apply for a Call on “Reaching an Understanding of Cancer"
To advance the understanding of cancer and accelerate ground-breaking discoveries and their translation into clinical applications, the canSERV consortium invites cancer researchers worldwide to apply for free access to cutting-edge, transnational research services and training.
In line with the EU Cancer Mission, canSERV aims to improve the comprehension of cancer and drivers of formation, malignancy and prognosis to eventually develop more effective cancer therapies. To support this, a budget of 750.000€ is available for the current Challenge-driven Call for Service Provision.
Projects submitted to this call should encompass various aspects related to advancing the understanding of cancer which may address, but are not limited to:
- Addressing cancer with poor prognosis
- Cancers with rising incidence
- Cancer and inflammation
- Identification of new modifiable cancer risk factors
- Identification of targets to develop biomarkers for prevention, early detection, personalised treatment and monitoring of minimal residual disease or relapse.
canSERV offers more than 400 innovative cancer research services to European and non-European cancer researchers at all levels. In this Challenge-driven Call, a minimum of two services from the canSERV Service Catalogue should be requested. Training is considered a separate additional service. The services can be requested for research proposals via the canSERV project website and the unique Common Access Management System. The services will be provided by 13 leading European Life Science Research Infrastructures and associated service providers in the following fields:
- Disease models
- Advanced technologies for personalised oncology
- Biomarkers research, development and validation
- New therapeutic solutions
- Accelerated translation into personalised oncology clinical practice
- Open digital research services
- Access to human samples and data
- Clinical trials and design
- Ethical, legal and socio-economic (ELSI) dimensions
- Training.
A detailed service list is available in the canSERV Service Catalogue.
Researchers based in European and non-European countries, including junior and senior individual researchers, academic institutes, biotech/pharmaceutical SMEs, groups of scientists, networks and consortia from public and private entities can apply for the call.
Call information:
The overall budget for this Challenge-driven Call is 0.75 Mio. EURO.
Launch of the second Challenge-driven call is today, Tuesday, 23 April 2024.
Submit your research proposals by 23 July, at 14.00 CEST.
Applications will be reviewed by an international, independent, expert review panel.
Further information:
canSERV website: www.canserv.eu
Twitter: @canSERV_EU
LinkedIn: canSERV
Project coordination, BBMRI-ERIC:
Prof. Jens K. Habermann, Director General
Judit Balogh, Senior project manager
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.
ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development in the EU. For more information, please visit www.arttic-innovation.de.
We take your privacy seriously. Click here to read our privacy policy. If you no longer wish to receive emails from us, please click below.
